1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
- 2022
-
Mark
Tau PET Imaging in Neurodegenerative Disorders
(2022) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 63. p.20-26
- Contribution to journal › Article
- 2021
-
Mark
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Solubility of Aβ40 peptide
- Contribution to journal › Article
-
Mark
In vivo tau pathology is associated with synaptic loss and altered synaptic function
- Contribution to journal › Article
- 2019
-
Mark
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42
(2019) In ACS Chemical Neuroscience
- Contribution to journal › Article
-
Mark
Antipsychotic Treatment Associated With Increased Mortality Risk in Patients With Dementia. A Registry-Based Observational Cohort Study
- Contribution to journal › Article
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment : the effect of age at onset
- Contribution to journal › Article
- 2018
-
Mark
G-score : A function to solve the puzzle of modeling the protonation states of β-secretase binding pocket
- Contribution to journal › Article
